Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA-199a-3p is a small non-coding RNA that functions as a tumor suppressor by regulating the expression of genes involved in cell proliferation, migration, and apoptosis. It is downregulated in various cancers, including osteosarcoma, hepatocellular carcinoma, and glioma. miR-199a-3p targets several oncogenes and anti-apoptotic genes, including Met, mTOR, Stat3, and Bcl-XL, thus inhibiting tumor growth and progression. Its potential as a therapeutic target or biomarker is being explored for cancer treatment.
Acts as a tumor suppressor by downregulating oncogenes and anti-apoptotic genes, such as Met, mTOR, Stat3, MCL-1, and Bcl-XL, which are involved in cell proliferation, survival, and migration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 199a-3p (miR-199a-3p).